PG PROCTER & GAMBLE Co
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · NYSE · SEC CIK 80424 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.5%
TTM net income YoY-4.4%
TTM EPS YoY-3.1%
Revenue 3-yr CAGR1.8%
Net income 3-yr CAGR1.7%
Margins
Gross margin49.8%
Operating margin22.6%
Net margin18.2%
FCF margin17.4%
EBITDA margin26.2%
Returns
ROE29.6%
ROA12.3%
ROIC (approx.)20.0%
Asset turnover0.67x
Leverage & solvency
Liabilities / assets58.4%
Debt / equity0.71x
Current ratio0.72x
Interest coverage21.98x
Cash quality & payout
Operating cash flow / net income1.24x
Accruals ratio-3.0%
Payout ratio64.2%
Capex / revenue5.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $87.03B | $84.28B | $84.04B | $82.01B | $80.19B |
| Cost of revenue | $43.36B | $41.16B | $40.85B | $42.76B | $42.16B |
| Gross profit | $43.67B | $43.12B | $43.19B | $39.25B | $38.03B |
| R&D expense | $2.10B | $2.10B | $2.00B | $2.00B | $2.00B |
| SG&A expense | $23.92B | $22.67B | $23.30B | $21.11B | $20.22B |
| Operating income | $19.75B | $20.45B | $18.55B | $18.13B | $17.81B |
| Interest expense | $877.00M | $907.00M | $925.00M | $756.00M | $439.00M |
| Pretax income | $20.38B | $20.17B | $18.76B | $18.35B | $18.00B |
| Income tax | $4.23B | $4.10B | $3.79B | $3.62B | $3.20B |
| Net income | $16.05B | $15.97B | $14.88B | $14.65B | $14.74B |
| EBITDA | $22.91B | $23.30B | $21.44B | $20.85B | $20.62B |
| EPS (basic) | 6.75 | 6.67 | 6.18 | 6.07 | 6.00 |
| EPS (diluted) | 6.62 | 6.51 | 6.02 | 5.90 | 5.81 |
| Dividends declared per share | 4.26 | 4.08 | 3.83 | 3.68 | 3.52 |
| Weighted avg. shares (diluted) | 2.42B | 2.45B | 2.47B | 2.48B | 2.54B |
| Balance sheet | |||||
| Cash & equivalents | $9.94B | $9.56B | $9.48B | $8.25B | $7.21B |
| Receivables | $6.06B | $6.18B | $6.12B | $5.47B | $5.14B |
| Inventory | $8.17B | $7.55B | $7.02B | $7.07B | $6.92B |
| Current assets | $26.21B | $25.39B | $24.71B | $22.65B | $21.65B |
| PP&E, net | $25.36B | $23.90B | $22.15B | $21.91B | $21.20B |
| Goodwill | $41.28B | $41.65B | $40.30B | $40.66B | $39.70B |
| Intangibles | $21.44B | $21.91B | $22.05B | $23.78B | $23.68B |
| Total assets | $126.52B | $125.23B | $122.37B | $120.83B | $117.21B |
| Current liabilities | $38.69B | $36.06B | $33.63B | $35.76B | $33.08B |
| Short-term debt | $11.30B | $9.51B | $7.19B | $10.23B | $8.64B |
| Long-term debt | $22.84B | $25.00B | $25.27B | $24.38B | $22.85B |
| Total debt | $34.14B | $34.51B | $32.46B | $34.61B | $31.49B |
| Total liabilities | $72.21B | $72.95B | $71.81B | $73.76B | $70.35B |
| Shareholders' equity | $54.08B | $52.01B | $50.29B | $46.78B | $46.59B |
| Net debt | $24.20B | $24.95B | $22.98B | $26.36B | $24.28B |
| Cash flow statement | |||||
| Operating cash flow | $19.56B | $17.82B | $19.85B | $16.85B | $16.72B |
| Capital expenditure | $4.41B | $3.77B | $3.32B | $3.06B | $3.16B |
| Free cash flow | $15.15B | $14.04B | $16.52B | $13.79B | $13.57B |
| Investing cash flow | -$4.62B | -$3.82B | -$3.50B | -$3.50B | -$4.42B |
| Financing cash flow | -$14.46B | -$14.04B | -$14.86B | -$12.15B | -$14.88B |
| Depreciation & amortization | $3.16B | $2.85B | $2.90B | $2.71B | $2.81B |
| Stock-based compensation | $524.00M | $476.00M | $562.00M | $545.00M | $528.00M |
| Dividends paid | $10.23B | $9.87B | $9.31B | $9.00B | $8.77B |
| Share buybacks | $5.03B | $6.50B | $5.01B | $7.35B | $10.00B |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.